Endorectal sonographic appearances of rectal MALT lymphoma, its response to therapy, and local recurrence

2001 ◽  
Vol 29 (7) ◽  
pp. 401-405 ◽  
Author(s):  
Margherita Gavioli ◽  
Alberto Bagni ◽  
Giovanni Santacroce ◽  
Italo Piccagli ◽  
Gianni Natalini
Keyword(s):  
Local Recurrence ◽  
Malt Lymphoma ◽  
Response To Therapy ◽  
Rectal Malt Lymphoma

scholarly journals Management of Local Soft Tissue Recurrent Osteosarcoma After Wide Resection and Reconstruction with Megaprosthesis: A Case Report

2019 ◽  
Vol 13 (4) ◽  
pp. 137
Author(s):  
Venansius Herry Perdana Suryanta ◽  
Muhammad Naseh Sajadi Budi
Keyword(s):  
Local Recurrence ◽  
Limb Salvage ◽  
Salvage Surgery ◽  
Malignant Neoplasm ◽  
Quadriceps Muscle ◽  
Response To Therapy ◽  
Wide Resection ◽  
Surgical Removal ◽  
Limb Salvage Surgery ◽  
Surgical Methods

Introduction: Limb salvage surgery involves all of the surgical methods to achieve the eradication of a malignant neoplasm and restoration of the limb with a satisfactory oncologic, functional, and cosmetic outcome. Rates of local recurrence are 4% to 10%. There is a chance of local recurrence from the contamination of biopsy path. Neoadjuvant chemotherapy has a guarding effect on managing neoplasm infiltration at the biopsy location.Case Presentation: An 18 year old male experienced a new painless lump at his right anterior thigh with size about 5 cm in diameter since 5 months ago. Previously, he underwent limb salvage surgery with megaprosthesis about 6 months ago due to osteosarcoma at his right distal femur. He also got neoadjuvant and adjuvant chemotherapy for 6 cycles. Mass removal was done and 1.5 cm mass in diameter was found within quadriceps muscle with a soft consistency and well-defined border from the previous biopsy site that had not been resected. The specimen result was osteosarcoma surrounded by tumor-free tissue. Postoperatively, he still had the same range of motion function as before.Conclusions: We need to consider the previously contaminated biopsy path that could lead to local recurrence. Factors that affect the prediction of the recurrent disease are the disease-free time period, location of recurrence and histological response to therapy and the capability to achieve total surgical removal. Tumor removal followed by the local radiation and chemotherapy is the preferred treatment for recurrence.

Non-MALT marginal zone B-cell lymphomas: a description of clinical presentation and outcome in 124 patients

Blood ◽  
2000 ◽  
Vol 95 (6) ◽  
pp. 1950-1956 ◽  
Author(s):  
Françoise Berger ◽  
Pascale Felman ◽  
Catherine Thieblemont ◽  
Thierry Pradier ◽  
Lucille Baseggio ◽  
...  
Keyword(s):  
B Cell ◽  
Malt Lymphoma ◽  
Marginal Zone ◽  
Clinical Presentation ◽  
B Cell Lymphoma ◽  
Complete Response ◽  
Response To Therapy ◽  
Time To Progression ◽  
Retrospective Nature ◽  
Clinical Description

Abstract Marginal zone B-cell lymphoma (MZL) is a recently individualized lymphoma that encompasses mucosa-associated lymphoid tissue (MALT) lymphoma, splenic lymphoma with or without villous lymphocytes, and nodal lymphoma with or without monocytoid B-cells. If the clinical description and outcome of MALT lymphoma is well known, this is not the case for the other subtypes. We reviewed 124 patients presenting non-MALT MZL treated in our department to describe the morphologic and clinical presentation and the outcome of these lymphomas. Four clinical subtypes were observed: splenic, 59 patients; nodal, 37 patients; disseminated (splenic and nodal), 20 patients; and leukemic (not splenic nor nodal), 8 patients. These lymphomas were usually CD5-, CD10-, CD23-, and CD43-, but the detection of one or, rarely, two of these antigens may be observed. Bone marrow and blood infiltrations were frequent, except in the nodal subtype, but these locations were not associated with a poorer outcome. Splenic and leukemic subtypes were associated with a median time to progression (TTP) longer than 5 years, even in the absence of treatment or of complete response to therapy. Nodal and disseminated subtypes were associated with a median TTP of 1 year. However, in all these subtypes, survival was good with a median survival of 9 years, allowing these lymphomas to be classified as indolent. Because of the retrospective nature of this analysis, no conclusion may be drawn on the therapeutic aspects, but conservative treatments seem recommended for leukemic and splenic subtypes.

Regression of rectal MALT lymphoma after antibiotic treatment in a patient negative for Helicobacter pylori

2011 ◽  
Vol 5 (1) ◽  
pp. 59-63 ◽  
Author(s):  
E. Ohara ◽  
Y. Kitadai ◽  
M. Onoyama ◽  
M. Ohnishi ◽  
K. Shinagawa ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Antibiotic Treatment ◽  
Malt Lymphoma ◽  
Rectal Malt Lymphoma

A Case of Helicobacter pylori Infection and Rectal MALT Lymphoma Following Erythema Nodosum

2007 ◽  
Vol 69 (2) ◽  
pp. 126-130
Author(s):  
Toshifumi YAMAOKA ◽  
Miwa ASHIDA ◽  
Kazuhiro SHIMIZU ◽  
Shinichi SATO ◽  
Shunzen CHIN ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Malt Lymphoma ◽  
Erythema Nodosum ◽  
Helicobacter Pylori Infection ◽  
Rectal Malt Lymphoma

The Possible Involvement of Micro-Organisms Other Than Helicobacter pylori in the Development of Rectal MALT Lymphoma in H. Pylori-Negative Patients

Endoscopy ◽  
2002 ◽  
Vol 34 (4) ◽  
pp. 343-346 ◽  
Author(s):  
H. Nakase ◽  
K. Okazaki ◽  
M. Ohana ◽  
K. Ikeda ◽  
K. Uchida ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Malt Lymphoma ◽  
Rectal Malt Lymphoma ◽  
H Pylori ◽  
Micro Organisms

A Case of Rectal MALT Lymphoma Treated by Endoscopic Resection

2008 ◽  
Vol 104 (1) ◽  
pp. 255-256 ◽  
Author(s):  
Abraham Mathew ◽  
Burt C Humburg ◽  
Michael G Bayer
Keyword(s):  
Endoscopic Resection ◽  
Malt Lymphoma ◽  
Rectal Malt Lymphoma

scholarly journals Rectal MALT lymphoma regression and anti-Helicobacter pylori therapy

QJM ◽  
2018 ◽  
Vol 111 (10) ◽  
pp. 737-738 ◽  
Author(s):  
Y Ito ◽  
H Ureshino ◽  
N Tsuruoka ◽  
T Noda
Keyword(s):  
Helicobacter Pylori ◽  
Malt Lymphoma ◽  
Rectal Malt Lymphoma

scholarly journals Helicobacter pylori-Negative Primary Rectal MALT Lymphoma: Complete Remission after Radiotherapy

2012 ◽  
Vol 6 (2) ◽  
pp. 319-327 ◽  
Author(s):  
Takuma Okamura ◽  
Tomoaki Suga ◽  
Yugo Iwaya ◽  
Tetsuya Ito ◽  
Shuichi Yokosawa ◽  
...  
Keyword(s):  
Helicobacter Pylori ◽  
Complete Remission ◽  
Malt Lymphoma ◽  
Rectal Malt Lymphoma
Sign in / Sign up

Export Citation Format

Share Document